COMMUNIQUÉ DE PRESSE publié le 03/06/2025 à 12:10, il y a 1 année 1 mois Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth Lobe Sciences Ltd. appoints Mr. Yong Yao as CFO & EVP, leveraging his 25 years of finance & biotech experience to drive financial strategy & growth. Strategic shift to full-time financial leadership Chief Financial Officer Executive Vice President Finance Strategy Lobe Sciences Yong Yao
BRÈVE publiée le 14/04/2025 à 13:05, il y a 1 année 3 mois Lobe Sciences lance un placement privé pour le développement de médicaments Placement Privé Essais Cliniques Sciences Du Lobe Cynaptec Pharmaceuticals Psilocine Conjuguée
BRÈVE publiée le 14/04/2025 à 13:05, il y a 1 année 3 mois Lobe Sciences Initiates Private Placement for Drug Development Private Placement Clinical Trials Lobe Sciences Conjugated Psilocin Cynaptec Pharmaceuticals
COMMUNIQUÉ DE PRESSE publié le 14/04/2025 à 13:00, il y a 1 année 3 mois Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM) Lobe Sciences announces US$6M private placement for Cynaptec to fund Conjugated Psilocin development. Option for additional US$20M included. Company focuses on lipid tech for orphan diseases Private Placement Lobe Sciences Lipid Technology Conjugated Psilocin Cynaptec
BRÈVE publiée le 05/04/2025 à 05:55, il y a 1 année 3 mois Lobe Sciences Provides Corporate Update on Recent Transactions Clinical Trials Convertible Notes FDA Feedback Lobe Sciences Psilocin Mucate
BRÈVE publiée le 05/04/2025 à 05:55, il y a 1 année 3 mois Lobe Sciences fournit une mise à jour de l'entreprise sur les transactions récentes Essais Cliniques Billets Convertibles Commentaires De La FDA Sciences Du Lobe Mucate De Psilocine
COMMUNIQUÉ DE PRESSE publié le 05/04/2025 à 05:50, il y a 1 année 3 mois Lobe Sciences Provides Corporate Update Lobe Sciences provides corporate update on recent transactions and business progress including patents and clinical study results. Focus on lipid technology solutions for medical needs Corporate Update Recent Transactions Lobe Sciences Lipid Technology Medical Needs
Publié le 28/07/2026 à 19:21, il y a 1 heure 52 minutes Saint-Gobain signs a framework agreement with Microsoft and enhances its leadership in AI for construction
Publié le 28/07/2026 à 19:21, il y a 1 heure 52 minutes Saint-Gobain signe un accord-cadre avec Microsoft et renforce son leadership dans l’Intelligence Artificielle pour la construction
Publié le 28/07/2026 à 18:25, il y a 2 heures 49 minutes ACCOR - Finalisation de la 1ere tranche du programme de rachat d'action
Publié le 28/07/2026 à 18:25, il y a 2 heures 49 minutes ACCOR - Completion of the 1st tranche of the share buyback programme
Publié le 28/07/2026 à 18:00, il y a 3 heures 14 minutes AXA: Information relating to the number of voting rights and shares making up the share capital on 30/06/2026
Publié le 28/07/2026 à 16:55, il y a 4 heures 19 minutes Unusual Machines Announces Record Date for 2026 Annual Meeting
Publié le 28/07/2026 à 15:00, il y a 6 heures 14 minutes Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
Publié le 28/07/2026 à 14:45, il y a 6 heures 29 minutes Trifecta Gold Introduces the Liam and Lois Projects, East-Central Yukon and Grants Stock Options
Publié le 28/07/2026 à 14:30, il y a 6 heures 44 minutes Sekur Private Data Reports 25% Month-Over-Month Increase in Average Revenue Per User as Premium Pivot Takes Hold
Publié le 28/07/2026 à 20:48, il y a 26 minutes EQS-Adhoc: Steyr Motors AG: Discussions about possible tender offer for all shares in Steyr Motors AG by Red Cat Holdings, Inc.
Publié le 28/07/2026 à 20:38, il y a 35 minutes Knorr-Bremse sells its global climate control business for trains
Publié le 28/07/2026 à 20:23, il y a 50 minutes Freelance.com: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE 1er semestre 2026
Publié le 28/07/2026 à 19:49, il y a 1 heure 25 minutes Medios AG: Earnings guidance for the financial year 2026 reduced – revenue guidance raised at the same time
Publié le 28/07/2026 à 19:40, il y a 1 heure 33 minutes EQS-Adhoc: Medios AG: Adjusted guidance for the financial year 2026